Published in Infect Immun on July 01, 2006
Surface display of N-terminally anchored invasin by Lactobacillus plantarum activates NF-κB in monocytes. Appl Environ Microbiol (2012) 0.88
Evaluation of recombinant invasive, non-pathogenic Eschericia coli as a vaccine vector against the intracellular pathogen, Brucella. J Immune Based Ther Vaccines (2009) 0.84
Yersinia pseudotuberculosis enterocolitis mimicking enteropathic γδ T-cell lymphoma with abnormal clonality. BMC Infect Dis (2014) 0.81
CD4(+) T Cell Priming as Biomarker to Study Immune Response to Preventive Vaccines. Front Immunol (2013) 0.81
Enhancing microparticle internalization by nonphagocytic cells through the use of noncovalently conjugated polyethyleneimine. Int J Nanomedicine (2012) 0.80
A Precise Temperature-Responsive Bistable Switch Controlling Yersinia Virulence. PLoS Pathog (2016) 0.75
T cell receptor antagonist peptides induce positive selection. Cell (1994) 18.66
Induction by antigen of intrathymic apoptosis of CD4+CD8+TCRlo thymocytes in vivo. Science (1990) 12.13
Multiple beta 1 chain integrins are receptors for invasin, a protein that promotes bacterial penetration into mammalian cells. Cell (1990) 8.41
The major histocompatibility complex-restricted antigen receptor on T cells. I. Isolation with a monoclonal antibody. J Exp Med (1983) 7.55
The neutrophil-activating protein (NAP-1) is also chemotactic for T lymphocytes. Science (1989) 6.89
The virulence plasmid of Yersinia, an antihost genome. Microbiol Mol Biol Rev (1998) 5.78
Discrimination between intracellular uptake and surface adhesion of bacterial pathogens. Science (1991) 3.64
Efficient major histocompatibility complex class I presentation of exogenous antigen upon phagocytosis by macrophages. Proc Natl Acad Sci U S A (1993) 3.27
Identification of the integrin binding domain of the Yersinia pseudotuberculosis invasin protein. EMBO J (1990) 3.10
Yersinia type III secretion: send in the effectors. J Cell Biol (2002) 3.04
Targeting the innate immune response with improved vaccine adjuvants. Nat Med (2005) 2.63
Yersinia enterocolitica invasin: a primary role in the initiation of infection. Proc Natl Acad Sci U S A (1993) 2.61
Immunohistochemical and electron microscopic study of interaction of Yersinia enterocolitica serotype O8 with intestinal mucosa during experimental enteritis. Infect Immun (1989) 2.60
Immune responses to Yersinia enterocolitica in susceptible BALB/c and resistant C57BL/6 mice: an essential role for gamma interferon. Infect Immun (1994) 2.45
Molecular and cell biology aspects of plague. Proc Natl Acad Sci U S A (2000) 2.07
Cellular mechanisms governing cross-presentation of exogenous antigens. Nat Immunol (2004) 1.97
Flagellin is an effective adjuvant for immunization against lethal respiratory challenge with Yersinia pestis. Infect Immun (2006) 1.92
Pathogenesis of defined invasion mutants of Yersinia enterocolitica in a BALB/c mouse model of infection. Infect Immun (1995) 1.92
Yersinia pathogenicity factors. Curr Top Microbiol Immunol (1994) 1.66
T lymphocytes mediate protection against Yersinia enterocolitica in mice: characterization of murine T-cell clones specific for Y. enterocolitica. Infect Immun (1992) 1.66
Biodegradable and biocompatible poly(DL-lactide-co-glycolide) microspheres as an adjuvant for staphylococcal enterotoxin B toxoid which enhances the level of toxin-neutralizing antibodies. Infect Immun (1991) 1.62
Experimental Yersinia enterocolitica infection in euthymic and T-cell-deficient athymic nude C57BL/6 mice: comparison of time course, histomorphology, and immune response. Infect Immun (1993) 1.60
Preferential positive selection of V alpha 2+ CD8+ T cells in mouse strains expressing both H-2k and T cell receptor V alpha a haplotypes: determination with a V alpha 2-specific monoclonal antibody. Eur J Immunol (1992) 1.58
IL-12 is essential for resistance against Yersinia enterocolitica by triggering IFN-gamma production in NK cells and CD4+ T cells. J Immunol (1996) 1.50
Flagellin fusion proteins as adjuvants or vaccines induce specific immune responses. Infect Immun (2004) 1.49
A region of the Yersinia pseudotuberculosis invasin protein enhances integrin-mediated uptake into mammalian cells and promotes self-association. EMBO J (1999) 1.48
Antigen degradation or presentation by MHC class I molecules via classical and non-classical pathways. Mol Immunol (2002) 1.31
Defense mechanisms in Peyer's patches and mesenteric lymph nodes against Yersinia enterocolitica involve integrins and cytokines. Infect Immun (1996) 1.28
Involvement of focal adhesion kinase in invasin-mediated uptake. Proc Natl Acad Sci U S A (1998) 1.22
A homolog of the human chemokine receptor CXCR1 is expressed in the mouse. Mol Immunol (2005) 1.18
Efficient uptake of Yersinia pseudotuberculosis via integrin receptors involves a Rac1-Arp 2/3 pathway that bypasses N-WASP function. Mol Microbiol (2001) 1.16
Contribution of the Mn-cofactored superoxide dismutase (SodA) to the virulence of Yersinia enterocolitica serotype O8. Infect Immun (1997) 1.16
Yersinia enterocolitica invasin triggers phagocytosis via beta1 integrins, CDC42Hs and WASp in macrophages. Cell Microbiol (2001) 1.13
Antigen targeting to CD11b allows efficient presentation of CD4+ and CD8+ T cell epitopes and in vivo Th1-polarized T cell priming. J Immunol (2004) 1.06
Controlled release microparticles for vaccine development. Vaccine (1991) 1.06
Ulex europaeus 1 lectin targets microspheres to mouse Peyer's patch M-cells in vivo. Vaccine (1998) 1.04
Cationic microparticles are an effective delivery system for immune stimulatory cpG DNA. Pharm Res (2001) 1.02
Role of M cells in intestinal barrier function. Ann N Y Acad Sci (2000) 1.01
Selective Rac1 inhibition in dendritic cells diminishes apoptotic cell uptake and cross-presentation in vivo. Blood (2004) 1.01
Interferon-gamma maintains the binding and functional capacity of receptors for IL-8 on cultured human T cells. Eur J Immunol (1998) 1.00
Attenuated Yersinia pseudotuberculosis carrier vaccine for simultaneous antigen-specific CD4 and CD8 T-cell induction. Infect Immun (2003) 0.98
Translocation of Yersinia entrocolitica across reconstituted intestinal epithelial monolayers is triggered by Yersinia invasin binding to beta1 integrins apically expressed on M-like cells. Cell Microbiol (2000) 0.97
Yersinia enterocolitica invasin protein triggers IL-8 production in epithelial cells via activation of Rel p65-p65 homodimers. FASEB J (2000) 0.96
Enhanced oral uptake of tomato lectin-conjugated nanoparticles in the rat. Pharm Res (1997) 0.96
Activation of NF-kappaB and IL-8 by Yersinia enterocolitica invasin protein is conferred by engagement of Rac1 and MAP kinase cascades. Cell Microbiol (2003) 0.95
Yersinia enterocolitica-mediated translocation of defined fusion proteins to the cytosol of mammalian cells results in peptide-specific MHC class I-restricted antigen presentation. Eur J Immunol (2000) 0.95
Induction of mucosal and systemic immune responses by immunization with ovalbumin entrapped in poly(lactide-co-glycolide) microparticles. Immunology (1994) 0.94
Synthetic peptides entrapped in microparticles can elicit cytotoxic T cell activity. Vaccine (1996) 0.93
Cutting edge: expression of chemokine receptor CXCR1 on human effector CD8+ T cells. J Immunol (2004) 0.93
Yersinia-hsp60-reactive T cells are efficiently stimulated by peptides of 12 and 13 amino acid residues in a MHC class II (I-Ab)-restricted manner. Clin Exp Immunol (1996) 0.92
Induction of CD8+ T cell responses by Yersinia vaccine carrier strains. Vaccine (2005) 0.92
Yersinia enterocolitica-induced interleukin-8 secretion by human intestinal epithelial cells depends on cell differentiation. Infect Immun (1998) 0.91
Phagocytic processing of antigens for presentation by class II major histocompatibility complex molecules. Cell Microbiol (1999) 0.91
The intestinal uptake of particles and the implications for drug and antigen delivery. J Anat (1996) 0.90
The biological role of invasin during a Yersinia enterocolitica infection. Infect Agents Dis (1993) 0.89
Immunological responses after immunisation of mice with microparticles containing antigen and single stranded RNA (polyuridylic acid). Vaccine (2005) 0.84
Attenuated Yersinia enterocolitica mutant strains exhibit differential virulence in cytokine-deficient mice: implications for the development of novel live carrier vaccines. Infect Immun (2003) 0.84
Survey of human-use adjuvants. Expert Rev Vaccines (2003) 0.81
Generation of both MHC class I- and class II-restricted antigenic peptides from exogenously added ovalbumin in murine phagosomes. FEBS Lett (2000) 0.79
Cytotoxic T-cell-mediated response against Yersinia pseudotuberculosis in HLA-B27 transgenic rat. Infect Immun (1999) 0.79
Antigen sampling by mucosal dendritic cells. Trends Mol Med (2005) 0.77
Delivery of the cholera toxin B subunit by using a recombinant Yersinia enterocolitica strain as a live oral carrier. Res Microbiol (1991) 0.76
Fluorescent In situ hybridization allows rapid identification of microorganisms in blood cultures. J Clin Microbiol (2000) 3.73
Biologic consequences of Stat1-independent IFN signaling. Proc Natl Acad Sci U S A (2001) 2.56
Immune responses to Yersinia enterocolitica in susceptible BALB/c and resistant C57BL/6 mice: an essential role for gamma interferon. Infect Immun (1994) 2.45
Endosymbiotic bacteria in worms as targets for a novel chemotherapy in filariasis. Lancet (2000) 2.04
IL-18 (IFN-gamma-inducing factor) regulates early cytokine production in, and promotes resolution of, bacterial infection in mice. J Immunol (1998) 1.73
Abiotrophia elegans sp. nov., a possible pathogen in patients with culture-negative endocarditis. J Clin Microbiol (1998) 1.68
Experimental Yersinia enterocolitica infection in rodents: a model for human yersiniosis. APMIS (1993) 1.60
Pneumocystis carinii carriage in immunocompetent patients with primary pulmonary disorders as detected by single or nested PCR. J Clin Microbiol (1999) 1.58
Early gamma interferon mRNA expression is associated with resistance of mice against Yersinia enterocolitica. Infect Immun (1994) 1.53
IL-12 is essential for resistance against Yersinia enterocolitica by triggering IFN-gamma production in NK cells and CD4+ T cells. J Immunol (1996) 1.50
Evidence of a leading role for VEGF in Bartonella henselae-induced endothelial cell proliferations. Cell Microbiol (2001) 1.48
Comparison of MB/BacT and BACTEC 460 TB systems for recovery of mycobacteria in a routine diagnostic laboratory. J Clin Microbiol (1999) 1.43
Comparison of fluorescent in situ hybridization and conventional culturing for detection of Helicobacter pylori in gastric biopsy specimens. J Clin Microbiol (2001) 1.37
Innate defenses of the intestinal epithelial barrier. Cell Mol Life Sci (2005) 1.35
The relationship between estrogen levels and diets of Caucasian American and Oriental immigrant women. Am J Clin Nutr (1986) 1.35
Carvedilol inhibits the cardiostimulant and thermogenic effects of MDMA in humans. Br J Pharmacol (2012) 1.23
Interaction of Bartonella henselae with endothelial cells results in rapid bacterial rRNA synthesis and replication. Cell Microbiol (2000) 1.19
Role of plasmid-encoded antigens of Yersinia enterocolitica in humoral immunity against secondary Y. enterocolitica infection in mice. Microb Pathog (1993) 1.19
Gordonia polyisoprenivorans septicemia in a bone marrow transplant patient. Eur J Clin Microbiol Infect Dis (2004) 1.18
Interleukin-2 is indispensable for development of immunological self-tolerance. Clin Immunol Immunopathol (1996) 1.16
C-terminal amino acid residues of the trimeric autotransporter adhesin YadA of Yersinia enterocolitica are decisive for its recognition and assembly by BamA. Mol Microbiol (2010) 1.16
The gene slyA of Salmonella typhimurium is required for destruction of M cells and intracellular survival but not for invasion or colonization of the murine small intestine. Infect Immun (1996) 1.14
Culture independent and rapid identification of bacterial pathogens in necrotising fasciitis and streptococcal toxic shock syndrome by fluorescence in situ hybridisation. Med Microbiol Immunol (2000) 1.14
Protective role for heat shock protein-reactive alpha beta T cells in murine yersiniosis. Infect Immun (1994) 1.13
Cell surface presentation of recombinant (poly-) peptides including functional T-cell epitopes by the AIDA autotransporter system. FEMS Immunol Med Microbiol (2000) 1.12
Interaction of polymorphonuclear leukocytes with Yersinia enterocolitica: role of the Yersinia virulence plasmid and modulation by the iron-chelator desferrioxamine B. J Infect Dis (1994) 1.10
Effects of local anaesthetics on prostaglandin biosynthesis in vitro. Biochim Biophys Acta (1974) 1.09
Wortmannin blocks Yersinia invasin-triggered internalization, but not interleukin-8 production by epithelial cells. Med Microbiol Immunol (1998) 1.09
Aggregation via the red, dry, and rough morphotype is not a virulence adaptation in Salmonella enterica serovar Typhimurium. Infect Immun (2008) 1.08
Chronic prosthetic hip infection caused by a small-colony variant of Escherichia coli. J Clin Microbiol (1998) 1.08
Gene expression patterns of epithelial cells modulated by pathogenicity factors of Yersinia enterocolitica. Cell Microbiol (2004) 1.03
Ambiguous role of interleukin-12 in Yersinia enterocolitica infection in susceptible and resistant mouse strains. Infect Immun (1998) 1.01
Postinfectious irritable bowel syndrome: follow-up of a patient cohort of confirmed cases of bacterial infection with Salmonella or Campylobacter. Neurogastroenterol Motil (2011) 1.00
Serum insulin and glucose in hyperinsulinemic subjects fed three different levels of sucrose. Am J Clin Nutr (1981) 1.00
Cytokine mRNA expression in intestinal tissue of interleukin-2 deficient mice with bowel inflammation. Gut (1997) 0.98
Translocation of Yersinia entrocolitica across reconstituted intestinal epithelial monolayers is triggered by Yersinia invasin binding to beta1 integrins apically expressed on M-like cells. Cell Microbiol (2000) 0.97
Yersinia enterocolitica invasin protein triggers IL-8 production in epithelial cells via activation of Rel p65-p65 homodimers. FASEB J (2000) 0.96
Haemorrhagic fever with renal syndrome in Germany. Lancet (1991) 0.94
Interferon consensus sequence binding protein confers resistance against Yersinia enterocolitica. Infect Immun (2000) 0.93
Yersinia-hsp60-reactive T cells are efficiently stimulated by peptides of 12 and 13 amino acid residues in a MHC class II (I-Ab)-restricted manner. Clin Exp Immunol (1996) 0.92
Deferoxamine B but not deferoxamine G1 inhibits cytokine production in murine bone marrow macrophages. J Infect Dis (1995) 0.92
An abundance of Escherichia coli is harbored by the mucosa-associated bacterial flora of interleukin-2-deficient mice. Infect Immun (2004) 0.92
Trimer stability of YadA is critical for virulence of Yersinia enterocolitica. Infect Immun (2010) 0.92
Clonal spread of meropenem-resistant Acinetobacter baumannii strains in hospitals in the Mediterranean region and transmission to South-west Germany. J Hosp Infect (2005) 0.91
Emergence of increasing linezolid-resistance in enterococci in a post-outbreak situation with vancomycin-resistant Enterococcus faecium. Epidemiol Infect (2007) 0.91
Discrimination between epidemic and non-epidemic glycopeptide-resistant E. faecium in a post-outbreak situation. J Hosp Infect (2007) 0.91
Yersinia enterocolitica-induced interleukin-8 secretion by human intestinal epithelial cells depends on cell differentiation. Infect Immun (1998) 0.91
Effects of antimalarial drugs on phospholipase A and lysophospholipase activities in plasma membrane, mitochondrial, microsomal and cytosolic subcellular fractions of rat liver. Biochim Biophys Acta (1985) 0.90
Evaluation of the ICT malaria Pf test for rapid post-mortem diagnosis of Plasmodium falciparum malaria in corpses examined for forensic reasons. Int J Legal Med (2000) 0.90
Bartholinitis due to Streptococcus pneumoniae: case report and review. Clin Infect Dis (1998) 0.90
The effect of leukocyte and platelet transfusion on the activation of intravascular coagulation by endotoxin in granulocytopenic and thrombocytopenic rabbits. Am J Pathol (1976) 0.89
Interaction of Listeria monocytogenes with the intestinal epithelium. FEMS Microbiol Lett (2000) 0.88
DNA immunization confers systemic, but not mucosal, protection against enteroinvasive bacteria. Eur J Immunol (1999) 0.86
Activation of intravascular coagulation by endotoxin: the significance of granulocytes and platelets. Br J Haematol (1976) 0.86
Interleukin-12 and interleukin-18 are indispensable for protective immunity against enteropathogenic Yersinia. Microb Pathog (2001) 0.85
Pulmonary toxoplasmosis in bone marrow transplant recipients: report of two cases and review. Clin Infect Dis (1999) 0.84
Rapid identification of pathogens in blood. Ann Intern Med (2000) 0.84
Effects of antimalarial drugs on several rat-liver lysosomal enzymes involved in phosphatidylethanolamine catabolism. Biochim Biophys Acta (1982) 0.83
Cat scratch disease due to Bartonella henselae infection mimicking parotid malignancy. Eur J Clin Microbiol Infect Dis (2001) 0.83
Efficacy and potential clinical applications of Pentaglobin, an IgM-enriched immunoglobulin concentrate suitable for intravenous infusion. Eur J Surg Suppl (1999) 0.82
In vivo tracking and protective properties of Yersinia-specific intestinal T cells. Clin Exp Immunol (1998) 0.81
Seroprevalence of Bartonella henselae in cats in Germany. J Med Microbiol (1999) 0.81
Rational live oral carrier vaccine design by mutating virulence-associated genes of Yersinia enterocolitica. Infect Immun (1999) 0.81
Effects of psychotropic drugs on prostaglandin biosynthesis in vitro. J Pharm Pharmacol (1975) 0.80
Effects of the anti-inflammatory serine esterase inhibitor, FOY, on phospholipase A2 (EC 3.1.1.4) activity in rabbit polymorphonuclear leukocytes. Pharmacol Res Commun (1983) 0.80
Microbial heat shock proteins as vaccine. Behring Inst Mitt (1997) 0.80
Life-threatening pneumonia caused by human cytomegalovirus and Mycoplasma pneumoniae coinfection in a young, immunocompetent patient. J Med Microbiol (2010) 0.79
[Endemic occurrence of hemorrhagic fever with renal syndrome in the Federal Republic of Germany]. Z Arztl Fortbild (Jena) (1991) 0.78
Subcellular distribution of glycosylphosphatidylinositol-specific phospholipase D in rat liver. Biochem J (1996) 0.78
Soft-tissue abscess caused by Salmonella enterica serovar Enteritidis at the site of melanoma metastasis. Clin Microbiol Infect (2004) 0.77
Hydrolytic degradation of phosphatidylethanolamine and phosphatidylcholine by isolated rat-liver lysosomes. Biochim Biophys Acta (1982) 0.77
Conjugation of hydroxyethyl starch to desferrioxamine (DFO) modulates the dual role of DFO in Yersinia enterocolitica infection. Clin Diagn Lab Immunol (2000) 0.77
Phospholipase A2 and prostaglandins in human seminal plasma. Adv Prostaglandin Thromboxane Res (1978) 0.76
Role of T-helper-cell subtypes and cytokines in immunity to Yersinia enterocolitica in susceptible and resistant strains of mice. Contrib Microbiol Immunol (1995) 0.76
Metallo-beta-lactamase expressing multi-resistant Acinetobacter baumannii transmitted in the operation area. J Hosp Infect (2004) 0.75
DNA vaccination using coexpression of cytokine genes with a bacterial gene encoding a 60-kDa heat shock protein. Med Microbiol Immunol (2000) 0.75
[On the mineral substance in the calcareous bodies of Squalus acanthias (Dornhai)]. Z Klin Chem Klin Biochem (1968) 0.75
Phosphatidylethanolamide derivatives of prostaglandins E1 and E2. Prostaglandins (1976) 0.75
[Importance of thrombocytes and leukocytes in the release of intravascular coagulation by endotoxin]. Verh Dtsch Ges Inn Med (1976) 0.75
Effects of the serine protease inhibitors FOY and FOY 305 on phospholipase A1 (EC 3.1.1.32) activity in rat - liver lysosomes. Pharmacol Res Commun (1983) 0.75
[The action of benzydamine on phospholipase activation]. Arzneimittelforschung (1987) 0.75
Effects of forced convection of heated air on insensible water loss and heat loss in preterm infants in incubators. J Pediatr (1982) 0.75
On the mechanism of lysophospholipase activity of secretory phospholipase A2 (EC 3.1.1.4): deacylation of monoacylphosphoglycerides by intrinsic sn-1 specificity and pH-dependent acyl migration in combination with sn-2 specificity. Biochim Biophys Acta (1997) 0.75
Computerized dietary analysis systems: a comparative view. J Am Diet Assoc (1983) 0.75
Inhibition of Na + - and K + -activated ATPase by the direct lytic factor of cobra venom (Naja naja). Biochim Biophys Acta (1972) 0.75
Extraction of prostaglandin from AgNO3-impregnated silica gel layers for biological assay. Naunyn Schmiedebergs Arch Pharmakol (1970) 0.75
Inhibitors of liver lysosomal acid phospholipase A1. Eur J Biochem (1988) 0.75
Inhibition of liver lysosomal acid phospholipase A1 by blood serum proteins. Biochem Int (1988) 0.75